Elon Musk warned on The Joe Rogan Experience that the U.S. faces bankruptcy as national debt tops $38 trillion and Social Security nears insolvency by 2032—arguing only AI and robotics can save the ...

Economist Mark Zandi of Moody's Analytics says two states—New York and California—could determine whether the United States ...

Federal Reserve Governor Christopher Waller questioned Chairman Jerome Powell's view that economic data is too limited to be ...

Uber Technologies (NYSE: UBER) has outperformed the market over the past 5 years by 6.75% on an annualized basis producing an average annual return of 21.96%. Currently, Uber Technologies has a market ...

Buying $100 In IRM: If an investor had bought $100 of IRM stock 5 years ago, it would be worth $388.20 today based on a price of $102.95 for IRM at the time of writing.

CommScope Holding Co has a lower P/E than the aggregate P/E of 315.21 of the Communications Equipment industry. Ideally, one might believe that the stock might perform worse than its peers, but it's ...

Analysts have provided BRC with 3 ratings, resulting in a consensus rating of Outperform. The average one-year price target stands at $3.0, suggesting a potential 138.1% upside.

Analysts are estimating that Medifast will report an earnings per share (EPS) of $-0.22. Medifast bulls will hope to hear the company announce they've not only beaten that estimate, but also to ...

Buying $1000 In MA: If an investor had bought $1000 of MA stock 15 years ago, it would be worth $21,537.71 today based on a price of $551.25 for MA at the time of writing.

Analysts anticipate Syndax Pharmaceuticals to report an earnings per share (EPS) of $-0.72. Investors in Syndax Pharmaceuticals are eagerly awaiting the company's announcement, hoping for news of ...

Analysts estimate that Myriad Genetics will report an earnings per share (EPS) of $-0.05. The announcement from Myriad Genetics is eagerly anticipated, with investors seeking news of surpassing ...

Oklo shares are trading lower Friday afternoon, continuing a volatile week driven by conflicting catalysts for the nuclear startup.